Compounds > 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline
Page last updated: 2024-09-03

7,8-dichloro-1,2,3,4-tetrahydroisoquinoline and oxidopamine

7,8-dichloro-1,2,3,4-tetrahydroisoquinoline has been researched along with oxidopamine in 1 studies

Compound Research Comparison

Studies
(7,8-dichloro-1,2,3,4-tetrahydroisoquinoline)		Trials
(7,8-dichloro-1,2,3,4-tetrahydroisoquinoline)		Recent Studies (post-2010)
(7,8-dichloro-1,2,3,4-tetrahydroisoquinoline)		Studies
(oxidopamine)		Trials
(oxidopamine)		Recent Studies (post-2010) (oxidopamine)
79008,63062,407

Protein Interaction Comparison

ProteinTaxonomy7,8-dichloro-1,2,3,4-tetrahydroisoquinoline (IC50)oxidopamine (IC50)
Glyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)8
DNA repair protein RAD52 homologHomo sapiens (human)0.779

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matta, SG; Sharp, BM; Singh, J1

Other Studies

1 other study(ies) available for 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline and oxidopamine

ArticleYear
Catecholamines mediate nicotine-induced adrenocorticotropin secretion via alpha-adrenergic receptors.
    Endocrinology, 1990, Volume: 127, Issue:4

    Topics: Adrenocorticotropic Hormone; Animals; Benzylamines; Brain; Brain Stem; Catecholamines; Hydroxydopamines; Isoquinolines; Male; Nicotine; Norepinephrine; Oxidopamine; Prazosin; Rats; Receptors, Adrenergic, alpha; Tetrahydroisoquinolines; Yohimbine

1990